Add like
Add dislike
Add to saved papers

Haematoporphyrin monomethyl ether-mediated photodynamic inactivation of the biofilms produced by standard and fluconazole-resistant Candida albicans strains.

BACKGROUND: The use of photodynamic antimicrobial chemotherapy (PACT) to treat localized Candida infections is an emerging and promising therapeutic approach.

AIM: To assess the photodynamic inactivation (PDI) efficacy of haematoporphyrin monomethyl ether (HMME) on the biofilms produced by standard (ATCC 10231) and fluconazole-resistant Candida albicans strains.

METHODS: The PDI efficacy was evaluated by incubating C. albicans biofilms with 0.01-10 μmol/L HMME for 30 min in the dark, followed by irradiation with 400-800 nm light for 30 min.

RESULTS: HMME inactivated the biofilms in a concentration-dependent manner in the presence of light, but it exhibited no significant toxicity without light. After treatment with 10 μmol/L HMME and irradiation for 30 min, 2.47 and 3.26 log10 reductions in survival were achieved for C. albicans ATCC 10231 and fluconazole-resistant C. albicans, respectively.

CONCLUSIONS: Biofilms formed by the two strains were sensitive to HMME-mediated PDI.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app